Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TGTX
#1266
TG Therapeutics, Inc.
34.2
9
USD
+1.48%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+1.48%
Mudança mensal
+21.60%
Mudança em 6 meses
+0.47%
Mudança anual
-11.00%
Fechamento anterior
33.7
9
Abrir
34.3
3
Bid
Ask
Mínimo
34.2
9
High
34.3
6
Volume
155
Mercados
Ações
Cuidados de saúde
TGTX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
140.59 M
142.82 M
146.36 M
154.42 M
157.07 M
159.69 M
—
Valuation ratios
Enterprise value
6.78 B
2.49 B
1.67 B
2.65 B
4.8 B
4.93 B
23.07 B
Price to earnings ratio
—
—
-7.92
189.33
200.67
10.76
276.14
Price to sales ratio
—
—
562.55
10.83
14.67
7.81
48.04
Price to cash flow ratio
—
—
-8.89
-80.56
-119.11
-194.24
-480.03
Price to book ratio
—
—
26.73
15.77
21.7
7.43
25.69
Enterprise value to EBITDA ratio
-24.81
-7.04
-8.35
121.78
108.29
37.94
260.33
Profitability ratios
Return on assets %
-0.45
-0.92
-1.02
0.04
0.04
0.42
0.45
Return on equity %
-0.54
-1.47
-3.39
0.08
0.11
0.69
0.8
Return on invested capital %
-1 649.24
-2 168.43
-1 554.62
145.45
108.67
425.88
421.36
Gross margin %
100
100
100
93.95
88.3
83.66
336.54
Operating margin %
-180 K
-5 154.28
-6 924.2
8.83
12.74
20.01
76.2
EBITDA margin %
-179.28 K
-5 130.75
-6 839.5
8.92
12.76
20.02
76.24
Net margin %
-183.8 K
-5 204.08
-7 121.54
5.42
7.11
72.56
277.85
Liquidity ratios
Quick ratio
—
—
—
5.18
5.03
3.29
12.17
Current ratio
6.99
5.06
3.16
5.92
6.25
4.1
15.81
Inventory turnover
—
—
—
0.35
0.51
0.85
0.7
Asset turnover
0
0.01
0.01
0.89
0.73
0.75
0.78
Solvency ratios
Debt to assets ratio
0.03
0.21
0.43
0.34
0.44
0.24
1.23
Debt to equity ratio
0.04
0.33
1.42
0.69
1.14
0.39
2.8
Long term debt to total assets ratio
0.01
0.18
0.37
0.3
0.42
0.23
1.19
Long term debt to total equity ratio
0.01
0.28
1.21
0.62
1.1
0.38
2.7
Per share metrics
Operating cash flow per share
—
—
-1.3
-0.21
-0.25
-0.15
-0.15
EBIT per share
—
—
-1.42
0.14
0.26
0.76
0.76
EBITDA per share
—
—
-1.41
0.14
0.26
0.76
0.76
Total debt per share
—
—
0.61
0.75
1.58
1.57
6.27
Cash per share
—
—
1.29
1.46
1.94
1.24
5.76
Net current asset value per share
—
—
1.24
2.14
3.53
3.91
15.68
Tangible book value per share
—
—
0.43
1.08
1.39
4.01
10.94
Working capital per share
—
—
0.85
1.78
2.97
2.96
11.71
Book value per share
—
—
0.43
1.08
1.39
4.01
10.94
Notícias
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX)
TG Therapeutics garante linha de crédito de US$ 750 milhões com Blue Owl
BRIUMVI demonstra eficácia em pacientes com esclerose múltipla altamente ativa
BRIUMVI shows efficacy in highly active multiple sclerosis patients
TG Therapeutics apresentará dados do BRIUMVI em congresso de neurologia
TG Therapeutics to present BRIUMVI data at neurology meeting
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG earnings missed by $0.23, revenue topped estimates
TG Therapeutics enfrenta teste de resultados com aceleração do Briumvi
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates